FindTrial
Sign In

National registry on Mucormycosis

Retrospective National MUCORMYCOSIS registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052320
Enrollment
500
Registered
2023-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B461- Rhinocerebral mucormycosis

Interventions

None listed

Sponsors

NONE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with Mucormycosis admitted during the COVID period

Exclusion criteria

Exclusion criteria: patients with terminal disease

Design outcomes

Primary

MeasureTime frame
DeathTimepoint: at 4 weeks—

Secondary

MeasureTime frame
loss of functionTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr GURPREET S WANDER

Dayanand Medical College and Hospital

drgswander@yahoo.com9815545316

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026